|
|
|
Volumn 24, Issue 1 SUPPL. 4, 1997, Pages
|
|
The role of interferon alfa in the treatment of metastatic melanoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
BLEOMYCIN;
CARMUSTINE;
CISPLATIN;
DACARBAZINE;
LOMUSTINE;
RECOMBINANT ALPHA INTERFERON;
RECOMBINANT INTERLEUKIN 2;
TAMOXIFEN;
VINCRISTINE;
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
INTERLEUKIN 2;
RECOMBINANT PROTEIN;
ADVANCED CANCER;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
FATIGUE;
FEVER;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MELANOMA;
METASTASIS;
MULTICENTER STUDY;
NAUSEA;
NEPHROTOXICITY;
NEUROTOXICITY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
VOMITING;
SKIN TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
INTERFERON-ALPHA;
INTERLEUKIN-2;
MELANOMA;
NEOPLASM METASTASIS;
RECOMBINANT PROTEINS;
SKIN NEOPLASMS;
|
|
EID: 0031064517
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (93)
|
|
References (35)
|
